Targeting Inflammation for Endometrial Cancer Prevention
Status
Conditions
Treatments
Study type
Funder types
Identifiers
Details and patient eligibility
About
This study examines risk assessment and identifies prevention strategies for endometrial cancer. Collecting samples of blood and urine and risk assessments from patients with benign conditions or endometrial cancer may help doctors learn if there is a relationship between chronic inflammation and increase in risk for endometrial cancer.
Full description
PRIMARY OBJECTIVE:
I. To develop a model for a biobank that can be expanded across the Mayo Enterprise and implemented at extramural collaborative sites, including underserved populations.
OUTLINE: This is an observational study.
Patients complete a risk factor questionnaire over 15 minutes. Patients also undergo collection of blood and urine during pre-operative visit and collection of tissue samples at the time of surgery.
Enrollment
Sex
Ages
Volunteers
Inclusion criteria
- Women over the age of 18 years old undergoing hysterectomy for any benign indication or endometrial cancer
Exclusion criteria
- Men
- Women under the age of 18 years
- Women with a history of cancer, except for endometrial cancer or non-melanoma skin cancer
- Women with type 1 diabetes
- Women that have received radiation or chemotherapy for cancer
Trial design
191 participants in 1 patient group
Trial contacts and locations
Loading...
Data sourced from clinicaltrials.gov
Clinical trials
Research sites
Resources
Legal